Drugmaker AbbVie expects Humira volume erosion to worsen
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of…
N2:MRCH
Moderna shares fall after judge sides with Arbutus in patent fight
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that…
Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product…
Gilead to buy CymaBay for $4.3 billion in bets on liver disease…
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for…
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
(Reuters) - Shares of Metagenomi Technologies, a genetic medicines company backed by…
Pfizer posts surprise 4th quarter profit, but key products miss on…
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit…
Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in…
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer,…
Johnson & Johnson forecasts as much as 6% sales growth in 2024
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday…
Pfizer looks beyond COVID after quarterly loss on Paxlovid charge
By Bhanvi Satija and Michael Erman (Reuters) - Pfizer on Tuesday urged investors to focus…
New COVID shots still hard to find for some Americans
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) - Americans have…